Dency M. Joseph

Dency Joseph practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

Dency Joseph's NPI, 1235606740, was assigned on November 1, 2018. Dency Joseph holds Texas license 138105.

Dency Joseph's primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.

Dency Joseph's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System. The medical group on file is Physicians Referral Service.

Dmand AI tracks the electronic health record (EHR) system at each site where Dency Joseph practices. Vendor and product names are available with a free account.

Acute care is Dency Joseph's primary specialty in the NPI Registry, under taxonomy code 363LA2100X. Dency Joseph is licensed in Texas.

CMS counts 156 Medicare patients who saw Dency Joseph in 2024. The largest group is 65 to 74, with 75 patients. 75% of them have diabetes, and 75% have high blood pressure. 12% are also on Medicaid. Their average risk score is 3.29, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dency Joseph's median patient age at 67, with 43% women.

In 2024, Dency Joseph wrote 112 Medicare Part D claims for 56 patients.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dency Joseph for performance year 2024, reported as part of a group. Dency Joseph accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 1 general payment to Dency Joseph from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. Beta Bionics, Inc. paid the most, $91.